HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chaliki, H Articles by Rowley, P T Search for Related Content PubMed PubMed Citation Articles by Chaliki, H Articles by Rowley, P T

Women's receptivity to testing for a genetic susceptibility to breast cancer.

H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall and P T Rowley

Department of Medicine, University of Rochester School of Medicine, NY 14642, USA.

Four hundred eighty-four patients undergoing mammography and 498 patients visiting their obstetrician-gynecologist were asked whether they would take a breast cancer 1 (BRCA1) test to detect a genetic susceptibility to breast cancer. More than 90% in both groups said they would take the test. Women were more likely to accept if they were regularly having breast examinations by a physician, believed that mammography effectively detects early breast cancer, and believed that early breast cancer is curable. If shown to have inherited a susceptibility, many reported that they would be very anxious, would want the test repeated, would examine their breasts more often than monthly, and would want mammography more often than yearly. Many also reported that they would recommend testing to relatives.

This article has been cited by other articles:

				L. A. Keogh, M. C. Southey, J. Maskiell, M.-A. Young, C. L. Gaff, J. Kirk, K. M. Tucker, D. Rosenthal, M. R.E. McCredie, G. G. Giles, et al. Uptake of Offer to Receive Genetic Information about BRCA1 and BRCA2 Mutations in an Australian Population-Based Study Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2258 - 2263. [Abstract] [Full Text] [PDF]

				K. Gwyn, S. W. Vernon, and P. M. Conoley Intention to Pursue Genetic Testing for Breast Cancer among Women due for Screening Mammography Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 96 - 102. [Abstract] [Full Text] [PDF]

				S. J. Cutler and L. G. Hodgson To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults American Journal of Alzheimer's Disease and Other Dementias, January 1, 2003; 18(1): 9 - 20. [Abstract] [PDF]

				D G R Evans and F Lalloo Risk assessment and management of high risk familial breast cancer J. Med. Genet., December 1, 2002; 39(12): 865 - 871. [Abstract] [Full Text] [PDF]

				M Welkenhuysen, G Evers-Kiebooms, M Decruyenaere, E Claes, and L Denayer A community based study on intentions regarding predictive testing for hereditary breast cancer J. Med. Genet., August 1, 2001; 38(8): 540 - 547. [Full Text] [PDF]

				W. F. Lawrence, B. N. Peshkin, W. Liang, C. Isaacs, C. Lerman, and J. S. Mandelblatt Cost of Genetic Counseling and Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Mutations Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 475 - 481. [Abstract] [Full Text]

				K. Bosompra, T. Ashikaga, B. S. Flynn, J. K. Worden, and L. J. Solomon Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model Health Educ. Res., April 1, 2001; 16(2): 157 - 172. [Abstract] [Full Text] [PDF]

				R. E. Myers, T. Hyslop, K. Jennings-Dozier, T. A. Wolf, D. Y. Burgh, J. A. Diehl, C. Lerman, and G. W. Chodak Intention to Be Tested for Prostate Cancer Risk among African-American Men Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1323 - 1328. [Abstract] [Full Text]

				K. Armstrong, K. Calzone, J. Stopfer, G. Fitzgerald, J. Coyne, and B. Weber Factors Associated with Decisions about Clinical BRCA1/2 Testing Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1251 - 1254. [Abstract] [Full Text]

				L HUMPHREYS, A G W HUNTER, A ZIMAK, A O'BRIEN, Y KORNELUK, and M CAPPELLI Why patients do not attend for their appointments at a genetics clinic J. Med. Genet., October 1, 2000; 37(10): 810 - 815. [Full Text]

				M. A. Hall and S. S. Rich Genetic Privacy Laws and Patients' Fear of Discrimination by Health Insurers: The View from Genetic Counselors J. Law Med. Ethics, September 1, 2000; 28(3): 245 - 257. [PDF]

				B. MEISER, P. BUTOW, A. BARRATT, G. SUTHERS, M. SMITH, A. COLLEY, E. THOMPSON, and K. TUCKER Attitudes to genetic testing for breast cancer susceptibility in women at increased risk of developing hereditary breast cancer J. Med. Genet., June 1, 2000; 37(6): 472 - 476. [Full Text]

				S. Woloshin, L. M. Schwartz, S. J. Byram, H. C. Sox, B. Fischhoff, and H. G. Welch Women's Understanding of the Mammography Screening Debate Arch Intern Med, May 22, 2000; 160(10): 1434 - 1440. [Abstract] [Full Text] [PDF]

				K. Brain, J. Gray, P. Norman, E. Parsons, A. Clarke, C. Rogers, R. Mansel, and P. Harper Why do women attend familial breast cancer clinics? J. Med. Genet., March 1, 2000; 37(3): 197 - 202. [Abstract] [Full Text]

				S. Shiloh, R. Ben-Sinai, and G. Keinan Effects of Controllability, Predictability, and Information-Seeking Style on Interest in Predictive Genetic Testing Pers Soc Psychol Bull, October 1, 1999; 25(10): 1187 - 1195. [Abstract] [PDF]

				I. M. Lipkus, D. Iden, J. Terrenoire, and J. R. Feaganes Relationships among Breast Cancer Concern, Risk Perceptions, and Interest in Genetic Testing for Breast Cancer Susceptibility among African-American Women with and without a Family History of Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 533 - 539. [Abstract] [Full Text]

				S. W. Vernon, E. R. Gritz, S. K. Peterson, C. A. Perz, S. Marani, C. I. Amos, and W. F. Baile Intention to Learn Results of Genetic Testing for Hereditary Colon Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 353 - 360. [Abstract] [Full Text] [PDF]

				C. Lerman, C. Hughes, J. L. Benkendorf, B. Biesecker, J. Kerner, J. Willison, N. Eads, D. Hadley, and J. Lynch Racial Differences in Testing Motivation and Psychological Distress following Pretest Education for BRCA1 Gene Testing Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 361 - 367. [Abstract] [Full Text] [PDF]

				S. J. Durfy, D. J. Bowen, A. McTiernan, J. Sporleder, and W. Burke Attitudes and Interest in Genetic Testing for Breast and Ovarian Cancer Susceptibility in Diverse Groups of Women in Western Washington Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 369 - 375. [Abstract] [Full Text] [PDF]

				L. G. Bluman, B. K. Rimer, D. A. Berry, N. Borstelmann, J. D. Iglehart, K. Regan, J. Schildkraut, and E. P. Winer Attitudes, Knowledge, and Risk Perceptions of Women With Breast and/or Ovarian Cancer Considering Testing for BRCA1 and BRCA2 J. Clin. Oncol., March 1, 1999; 17(3): 1040 - 1040. [Abstract] [Full Text] [PDF]

				C. Lerman, K. Schulman, S. Narod, and H. Lynch Genetic Testing of Families With Hereditary Diseases-Reply JAMA, October 9, 1996; 276(14): 1140 - 1140. [Abstract] [PDF]

				C. Lerman, S. Narod, K. Schulman, C. Hughes, A. Gomez-Caminero, G. Bonney, K. Gold, B. Trock, D. Main, J. Lynch, et al. BRCA1 Testing in Families With Hereditary Breast-Ovarian Cancer: A Prospective Study of Patient Decision Making and Outcomes JAMA, June 26, 1996; 275(24): 1885 - 1892. [Abstract] [PDF]